Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.

AB Science SA (Euronext - FR0010557264 - AB) today reports its revenues for the year 2024 and provides an update on its activities. CLINICAL DEVELOPMENT KEY EVENTS DURING THE YEAR 2024 AND SINCE ...

Seventy-five years of preparation for an outbreak like that of COVID-19—and yet, the CDC still failed to “reliably meet ...

Donald Trump has recently made a range of nominations/appointments in the US health sector. They will influence conventional and so-called alternative medicine (SCAM) in the US and beyond. It ...